Search research articles
Contact Us
Filters
Showing results (171-180 of 208) with videos related to
Page
of 21
Sort By:
European Urology Open Science
|
May 11, 2022
What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes
Vasileios I Sakalis, Riccardo Campi, Lenka Barreto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2017
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Emmanuel S Antonarakis, Scott T Tagawa, Giuseppe Galletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
Jamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Nature Communications
|
July 7, 2019
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Brian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Lisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens
Neal D Shore, Matthew P Morrow, Trevor McMullan, et al.
World Journal of Urology
|
July 27, 2012
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
Michael Rink, Shahrokh F Shariat, Evanguelos Xylinas, et al.
Cancer Discovery
|
January 10, 2024
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation
Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno, et al.
Prostate Cancer and Prostatic Diseases
|
August 12, 2024
Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study
Julie N Graff, Christopher J Hoimes, Winald R Gerritsen, et al.
BJU International
|
September 24, 2013
Predictors of survival in patients with disease recurrence after radical nephroureterectomy
Luis A Kluth, Evanguelos Xylinas, Matthew Kent, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 208) with videos related to
Sort By:
Page
of 21
European Urology Open Science
|
May 11, 2022
What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes
Vasileios I Sakalis, Riccardo Campi, Lenka Barreto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2017
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Emmanuel S Antonarakis, Scott T Tagawa, Giuseppe Galletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
Jamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Nature Communications
|
July 7, 2019
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Brian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Lisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens
Neal D Shore, Matthew P Morrow, Trevor McMullan, et al.
World Journal of Urology
|
July 27, 2012
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
Michael Rink, Shahrokh F Shariat, Evanguelos Xylinas, et al.
Cancer Discovery
|
January 10, 2024
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation
Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno, et al.
Prostate Cancer and Prostatic Diseases
|
August 12, 2024
Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study
Julie N Graff, Christopher J Hoimes, Winald R Gerritsen, et al.
BJU International
|
September 24, 2013
Predictors of survival in patients with disease recurrence after radical nephroureterectomy
Luis A Kluth, Evanguelos Xylinas, Matthew Kent, et al.
Page
of 21